IS4837A - Pýrrólópýrrólón afleiður sem latar fyrir hlutleysis elastasa - Google Patents

Pýrrólópýrrólón afleiður sem latar fyrir hlutleysis elastasa

Info

Publication number
IS4837A
IS4837A IS4837A IS4837A IS4837A IS 4837 A IS4837 A IS 4837A IS 4837 A IS4837 A IS 4837A IS 4837 A IS4837 A IS 4837A IS 4837 A IS4837 A IS 4837A
Authority
IS
Iceland
Prior art keywords
neutralization
inhibit elastase
pyrrolopyrrolone
derivatives
pyrrolopyrrolone derivatives
Prior art date
Application number
IS4837A
Other languages
English (en)
Inventor
Dennis Dowle Michael
Finch Harry
Andrew Harrison Lee
George Adam Inglis Graham
Redpath Johnson Martin
John Fawcett Macdonald Simon
Shah Pritom
Andrew Smith Robin
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606508.1A external-priority patent/GB9606508D0/en
Priority claimed from GBGB9623001.6A external-priority patent/GB9623001D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS4837A publication Critical patent/IS4837A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
IS4837A 1996-03-28 1998-08-28 Pýrrólópýrrólón afleiður sem latar fyrir hlutleysis elastasa IS4837A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9606508.1A GB9606508D0 (en) 1996-03-28 1996-03-28 Chemical componds
GBGB9623001.6A GB9623001D0 (en) 1996-11-05 1996-11-05 Chemical compounds
PCT/EP1997/001530 WO1997036903A1 (en) 1996-03-28 1997-03-26 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (1)

Publication Number Publication Date
IS4837A true IS4837A (is) 1998-08-28

Family

ID=26309008

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4837A IS4837A (is) 1996-03-28 1998-08-28 Pýrrólópýrrólón afleiður sem latar fyrir hlutleysis elastasa

Country Status (30)

Country Link
US (3) US5994344A (is)
EP (1) EP0891362B1 (is)
JP (1) JP4118337B2 (is)
KR (1) KR20000005039A (is)
CN (1) CN1067075C (is)
AP (1) AP823A (is)
AR (1) AR006401A1 (is)
AT (1) ATE261969T1 (is)
AU (1) AU726649B2 (is)
BR (1) BR9708449A (is)
CA (1) CA2250209A1 (is)
CO (1) CO4790152A1 (is)
CZ (1) CZ309798A3 (is)
DE (1) DE69728139T2 (is)
DK (1) DK0891362T3 (is)
EA (1) EA001437B1 (is)
EE (1) EE9800335A (is)
ES (1) ES2217404T3 (is)
HU (1) HUP9900567A3 (is)
IL (1) IL125859A0 (is)
IS (1) IS4837A (is)
NO (1) NO984470L (is)
NZ (1) NZ331490A (is)
PE (1) PE55298A1 (is)
PL (1) PL329153A1 (is)
PT (1) PT891362E (is)
SK (1) SK132498A3 (is)
TR (1) TR199801935T2 (is)
WO (1) WO1997036903A1 (is)
YU (1) YU41198A (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9719189D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd New therapeutic method
PE107899A1 (es) * 1997-09-09 1999-11-17 Glaxo Group Ltd Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
GB9719187D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9719172D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9821199D0 (en) * 1998-09-30 1998-11-25 Glaxo Group Ltd Chemical compounds
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
WO2004081015A1 (en) * 2003-03-10 2004-09-23 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
JP4736043B2 (ja) 2003-03-14 2011-07-27 小野薬品工業株式会社 含窒素複素環誘導体およびそれらを有効成分とする薬剤
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
US7692037B2 (en) * 2004-09-02 2010-04-06 Eastman Chemical Company Optimized liquid-phase oxidation
KR101231466B1 (ko) 2004-09-13 2013-02-07 오노 야꾸힝 고교 가부시키가이샤 질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는약제
GB0512238D0 (en) * 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
JPWO2007105637A1 (ja) 2006-03-10 2009-07-30 小野薬品工業株式会社 含窒素複素環誘導体およびそれらを有効成分とする薬剤
JP2010535705A (ja) * 2007-04-23 2010-11-25 シガ テクノロジーズ，インコーポレーテッド オルソポックスウイルス感染及び関連疾患の治療及び予防のための化学物質、組成物、及び方法
JP5544296B2 (ja) 2007-11-16 2014-07-09 ライジェル ファーマシューティカルズ， インコーポレイテッド 代謝障害のためのカルボキサミド、スルホンアミド、およびアミン化合物
ES2553340T3 (es) 2007-12-12 2015-12-07 Rigel Pharmaceuticals, Inc. Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos
MX2010011288A (es) 2008-04-23 2010-11-09 Rigel Pharmaceuticals Inc Compuestos de carboxamida para el tratamiento de trastornos metabolicos.
EP2935274B1 (en) * 2012-12-18 2018-10-03 Chiesi Farmaceutici S.p.A. 3-oxo-2,3,5,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrimidine derivatives for the treatmetn of respiratory diseases
BR112022004861A2 (pt) 2019-09-17 2022-06-07 Univ Duke Alvelestat para uso no tratamento de rejeição de transplante, síndrome de bronquiolite obliterante e doença de transplante versus hospedeiro
SI4106757T1 (sl) 2020-04-16 2023-11-30 Mereo Biopharma 4 Limited Postopki, ki vključujejo zaviralec nevtrofilne elastaze alvelestat, za zdravljenje bolezni dihal, ki jo sproži pomanjkanje antitripsina alfa-1
IL312002A (en) 2021-10-20 2024-06-01 Mereo Biopharma 4 Ltd Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2932650A (en) * 1957-11-19 1960-04-12 Arthur C Cope 2-6-diazabicyclo (3. 3. 0) octanes
US4997950A (en) * 1989-04-20 1991-03-05 Richard Finbar Murphy Novel C-terminal gastrin antagonists
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US5610296A (en) * 1994-12-05 1997-03-11 G. D. Searle & Co. Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs

Also Published As

Publication number Publication date
AU2291797A (en) 1997-10-22
AP9801351A0 (en) 1998-09-30
NO984470D0 (no) 1998-09-25
PE55298A1 (es) 1998-09-19
DE69728139D1 (de) 2004-04-22
AU726649B2 (en) 2000-11-16
PL329153A1 (en) 1999-03-15
SK132498A3 (en) 1999-08-06
ES2217404T3 (es) 2004-11-01
CO4790152A1 (es) 1999-05-31
JP2000507950A (ja) 2000-06-27
US6057457A (en) 2000-05-02
CA2250209A1 (en) 1997-10-09
BR9708449A (pt) 1999-08-03
EA199800773A1 (ru) 1999-06-24
US5994344A (en) 1999-11-30
HUP9900567A3 (en) 2001-02-28
EE9800335A (et) 1999-04-15
IL125859A0 (en) 1999-04-11
AP823A (en) 2000-04-25
CN1219935A (zh) 1999-06-16
KR20000005039A (ko) 2000-01-25
NZ331490A (en) 2000-06-23
JP4118337B2 (ja) 2008-07-16
YU41198A (sh) 1999-09-27
PT891362E (pt) 2004-08-31
HUP9900567A2 (hu) 1999-06-28
TR199801935T2 (xx) 1999-03-22
CZ309798A3 (cs) 1999-02-17
EP0891362B1 (en) 2004-03-17
NO984470L (no) 1998-11-25
EP0891362A1 (en) 1999-01-20
AR006401A1 (es) 1999-08-25
WO1997036903A1 (en) 1997-10-09
US6215002B1 (en) 2001-04-10
DK0891362T3 (da) 2004-07-12
DE69728139T2 (de) 2004-10-21
ATE261969T1 (de) 2004-04-15
EA001437B1 (ru) 2001-02-26
CN1067075C (zh) 2001-06-13

Similar Documents

Publication Publication Date Title
IS4837A (is) Pýrrólópýrrólón afleiður sem latar fyrir hlutleysis elastasa
FI960525A0 (fi) Framstaellning av mellandestillat
FI961551A0 (fi) Menylett utforming av kortmeddelanden
FI962166A0 (fi) Foerfarande foer bestaemmande av utbredningsdaempning av radiovaogor
IS5391A (is) Pýrrólópýrrólón afleiður sem latar fyrir hlutleysiskirnings elastasa
IS5394A (is) Pýrrólópýrrólón afleiður sem latar fyrir hlutleysiskirnings elastasa
FI960501A0 (fi) Foerfarande foer omkastning av uppkopplingsriktningen av samtal
ATA83196A (de) Wäschetrockner
KR970058483U (ko) 건조기
KR970063497U (ko) 연속식 건조기
FI960962A0 (fi) Foerfarande foer framstaellning av en flerskiktskartongprofil
FI961041A0 (fi) Klingledare av saogmaskin
IT1282129B1 (it) Asciugabiancheria
KR970055619U (ko) 건조기
SK2106U (sk) Sušič
SE9600547D0 (sv) Bineg algoritmen
FI963207A0 (fi) Antennkonstruktion foer eliminering/minskning av de biologiska skadeverkningarna av en ficktekfons mikrovaogsstaolningsfaelt
KR970058653U (ko) 크레센트
KR980001183U (ko) 렌치
FI960164A0 (fi) Anordning foer behandling av avgaser
FI961256A0 (fi) Anordning foer aostadkommande av en luftstroem
FI963711A0 (fi) Foerfarande foer framstaellning av traematerial
FI964838A0 (fi) Hoernstycke foer hopmontering av laodor
FI964906A0 (fi) Genomfoeringens oeppningskonstruktion av en mellanvaeggsslana
FI962674A0 (fi) Foerfarande foer renovering av en barkningstrumma